Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders

Melatonin is registered to treat circadian rhythm sleep–wake disorders and insomnia in patients aged 55 years and over. The essential role of the circadian sleep rhythm in the deterioration of sleep quality during COVID-19 confinement and the lack of an adverse effect of melatonin on respiratory dri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wichniak, Adam, Kania, Aleksander, Siemiński, Mariusz, Cubała, Wiesław Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395320/
https://www.ncbi.nlm.nih.gov/pubmed/34445329
http://dx.doi.org/10.3390/ijms22168623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395320/
https://www.ncbi.nlm.nih.gov/pubmed/34445329
http://dx.doi.org/10.3390/ijms22168623

Ejemplares similares